CHMP Recommends Astellas Pharma Europe Ltd.’s (APEL) DIFICLIR™ for Approval in the EU – Boston Globe

Optimer has a further anti-infective product in development. Additional information can be found at http://www.optimerpharma.com/. 1. European Medicines Agency. Dificlir [Internet] 2011 September 22 [updated 2011 September 23; cited 2011 …